Interleukin-17: A potential therapeutic target in COVID-19

por Mendoza, Vicky M. Montaño
Publicado 2020

SARS-CoV-2 and superimposed infection by trichomonads

por Duboucher, Christophe
Publicado 2021

Contamination of personal protective equipment by SARS-CoV-2 during routine care of patients with mild COVID-19

por Jung, Jiwon, Kim, Ji Yeun, Bae, Seongman, Cha, Hye-Hee, Kim, Eun Ok, Kim, Min Jae, Kim, Sung-Han
Publicado 2020

Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients

por Cento, Valeria, Colagrossi, Luna, Nava, Alice, Lamberti, Anna, Senatore, Sabrina, Travi, Giovanna, Rossotti, Roberto, Vecchi, Marta, Casati, Ornella, Matarazzo, Elisa, Bielli, Alessandra, Casalicchio, Giorgia, Antonello, Maria, Renica, Silvia, Costabile, Valentino, Scaglione, Francesco, Fumagalli, Roberto, Ughi, Nicola, Epis, Oscar Massimiliano, Puoti, Massimo, Vismara, Chiara, Faccini, Marino, Fanti, Diana, Alteri, Claudia, Perno, Carlo Federico
Publicado 2020

High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?

por Barrasa, Helena, Martín, Alejandro, Maynar, Javier, Rello, Jordi, Fernández-Torres, Marina, Aguirre-Quiñonero, Amaia, Canut-Blasco, Andrés
Publicado 2021

Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan

por Tanaka, Akihito, Yamamoto, Shohei, Miyo, Kengo, Mizoue, Tetsuya, Maeda, Kenji, Sugiura, Wataru, Mitsuya, Hiroaki, Sugiyama, Haruhito, Ohmagari, Norio
Publicado 2021

Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan

por Rana, Muhammad Suleman, Usman, Muhammad, Alam, Muhammad Masroor, Ikram, Aamer, Salman, Muhammad, Zaidi, Syed Sohail Zahoor, Umair, Massab, Qadir, Mehmood
Publicado 2021

Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France

por Dimeglio, Chloé, Miedougé, Marcel, Loubes, Jean-Michel, Mansuy, Jean-Michel, Izopet, Jacques
Publicado 2021

Protecting healthcare workers in conflict zones during the COVID-19 pandemic: Northwest Syria

por Almhawish, Naser, Karah, Nabil, Elferruh, Yasir, Aksh, Aya, Abbara, Aula
Publicado 2021

High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort

por Tubiana, Sarah, Burdet, Charles, Houhou, Nadhira, Thy, Michael, Manchon, Pauline, Blanquart, François, Charpentier, Charlotte, Guedj, Jérémie, Alavoine, Loubna, Behillil, Sylvie, Leclercq, Anne, Lucet, Jean-Christophe, Yazdanpanah, Yazdan, Attia, Mikaël, Demeret, Caroline, Rose, Thierry, Bielicki, Julia Anna, Bruijning-Verhagen, Patricia, Goossens, Herman, Descamps, Diane, van der Werf, Sylvie, Lina, Bruno, Duval, Xavier
Publicado 2021

Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK

por Toovey, Oliver T.R., Harvey, Kirsty N., Bird, Paul W., Tang, Julian Wei-Tze Wei-Tze
Publicado 2021

Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study

por Borgonovo, Fabio, Passerini, Matteo, Piscaglia, Marco, Morena, Valentina, Giacomelli, Andrea, Oreni, Letizia, Dedivitiis, Gianfranco, Lupo, Angelica, Falvella, Stefania, Cossu, Maria Vittoria, Capetti, Amedeo F.
Publicado 2021

Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?

por de Montmollin, Etienne, Faille, Dorothée, Andrieu, Valérie, Ajzenberg, Nadine, Timsit, Jean-François
Publicado 2021

Early clinical experience with imatinib in COVID-19: Searching for a dual effect

por Morales-Ortega, Alejandro, Rivas-Prado, Luis, Frutos-Pérez, Begoña, Jaenes-Barrios, Beatriz, Farfán-Sedano, Ana Isabel, García-Parra, Carlos Javier, Hernández-Muniesa, Belén, Duarte-Millán, Miguel Ángel, Madroñal-Cerezo, Elena, Ontañón-Nasarre, Ana, Ruiz-Giardín, José Manuel, Bermejo, Fernando, García-Gil, Mario, Gonzalo-Pascua, Sonia, San Martín-López, Juan Víctor, Bernal-Bello, David
Publicado 2021

The chilly climate may increase the chance of infecting COVID-19

por Li, Gen, Niu, Jiawei, Fan, Xuelei, Chen, Tianbao, He, Dongsheng
Publicado 2021

Concerning the OptiGene Direct LAMP assay, and it’s use in at-risk groups and hospital staff

por Wilson-Davies, Eleri S.W., Mahanama, Adhyana I.K., Samaraweera, Buddhini, Ahmed, Nusreen, Friar, Simon, Pelosi, Emanuela
Publicado 2021

Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers

por Downs, Louise O, Eyre, David W, O'Donnell, Denise, Jeffery, Katie
Publicado 2021

Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study

por Kevorkian, Jean-Philippe, Lopes, Amanda, Sène, Damien, Riveline, Jean-Pierre, Vandiedonck, Claire, Féron, Florine, Nassarmadji, Kladoum, Mouly, Stéphane, Mauvais-Jarvis, Franck, Gautier, Jean-François, Mégarbane, Bruno
Publicado 2021

Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19

por Scutt, Dr Greg, Overall, Dr Andrew
Publicado 2021

Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study

por Lora-Tamayo, Jaime, Maestro, Guillermo, Lalueza, Antonio, Rubio-Rivas, Manuel, Villarreal Paul, Gracia, Arnalich Fernández, Francisco, Beato Pérez, José Luis, Vargas Núñez, Juan Antonio, Llorente Barrio, Mónica, Lumbreras Bermejo, Carlos
Publicado 2021